Faced with the refusal of large pharmaceutical companies to provide information on the vaccines that are currently applied against covid-19, South Africa chose to develop its own biological with the support of the World Health Organization (WHO).
Gemma Parellada tells about this ambitious project that seeks to produce and distribute the first African vaccine against the virus, and thus balance its access in countries with few resources.
